Cancer Home > Imatinib 400 Mg

Imatinib mesylate (Gleevec®) is a tyrosine kinase inhibitor, which is a class of chemotherapy medicines. This medication can be used in the treatment of certain types of cancer, such as:
  • Leukemia and other cancers of the blood and bone marrow
  • Gastrointestinal stromal tumors (GIST, a cancer of the digestive tract)
  • A rare type of skin cancer known as dermatofibrosarcoma protuberans.
Imatinib comes in tablet form and is available in the following strengths:
  • Imatinib 100 mg
  • Imatinib 400 mg.
(Click Imatinib to learn about possible side effects, how your healthcare provider will determine your dose, what to do in cases of overdose, and more.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.